Clinical Trial Update: Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating droxidopa and droxidopa/carbidopa for potential clinical benefit in fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Droxidopa (Droxidopa)
• Droxidopa/Carbidopa (droxidopa/carbidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED